PD-L1, an immune checkpoint protein expressed on the many normal tissue cell and tumor cell surfaces, binds to PD-1 on active T cells, thereby preventing cell recognition by CTLs, diminishing immune responses, and inhibiting CTL activities, including cytokine secretion, lymphocyte proliferation, and activation. Here, PDCD1 is linked to neoplasm.